XML 31 R20.htm IDEA: XBRL DOCUMENT v3.26.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Equity Incentive Plans
2021 Plan
In July 2021, the Company adopted the 2021 Stock Incentive Plan (“2021 Plan”). The 2021 Plan allows the Board to grant up to 35 incentive and nonqualified stock options, restricted shares, unrestricted shares, restricted share units, and other stock-based awards for the Class A Common Stock to employees, directors, and non-employees. The number of shares of Class A Common Stock available under the 2021 Plan will increase annually on the first day of each calendar year, beginning with the calendar year ending December 31, 2024, and continuing until (and including) the calendar year ending December 31, 2031. Annual increases are equal to the lesser of (i) 5 percent of the number of shares of Class A Common Stock issued and outstanding on December 31 of the immediately preceding fiscal year and (ii) an amount determined by the Board.
As of the effective date of the 2021 Plan, no further stock awards have been or will be granted under the EI Plan or STI Plan (defined below).
At the annual meeting of stockholders held on July 31, 2024, the Company’s stockholders approved (among other proposals) an amendment to the 2021 Plan to increase the number of shares of Class A Common Stock available for issuance under the 2021 Plan by an additional 14,709 shares, subject to proportionate adjustment for stock splits and similar events as provided in the 2021 Plan.
At the stockholder’s meeting held September 19, 2025, the Company’s stockholders approved an amendment to the Company’s Amended and Restated 2021 Stock Incentive Plan in order to increase the number of shares of FFAI Class A
Common Stock available for issuance under the 2021 Plan by an additional 63,334 shares. The intent of this increase is to bring authorized shares under the 2021 Plan close to industry level.
On August 17, 2026, the Company filed a registration statement on Form S-8 registering an additional 488,227 shares of Class A Common Stock issuable under the 2021 Plan. During the three months ended September 30, 2026, the Company granted 330,152 RSUs under the 2021 Plan in connection with its employee salary-reduction program.
As of September 30, 2026, and 2025, the Company had 159,814 and 66,900 shares of Class A Common Stock, respectively, available for future issuance under the 2021 SI Plan.
EI Plan
On February 1, 2018, the Board adopted the Equity Incentive Plan (“EI Plan”), under which the Board authorized the grant of up to 30 incentive and nonqualified stock options, restricted stock, unrestricted stock, restricted stock units, and other stock-based awards for Legacy FF’s Class A Ordinary Stock to employees, directors and non-employees.
On the closing date and in connection with the Business Combination, each of the Legacy FF’s outstanding options under the EI Plan immediately prior to the closing of the Business Combination remained outstanding and converted into the right to purchase the Company’s Class A Common Stock based on the Exchange Ratio.
As of September 30, 2026, there was no unrecognized stock-based compensation expense for stock options granted under the EI Plan.
STI Plan
On May 2, 2019, the Company adopted its Special Talent Incentive Plan (“STI Plan”) under which the Board may grant up to 10 incentive and nonqualified stock options, restricted shares, unrestricted shares, restricted share units, and other stock-based awards for Legacy FF’s Class A Ordinary Stock to employees, directors, and non-employees.
The STI Plan does not specify a limit on the number of stock options that may be issued under the plan. Under the terms of the STI Plan, the Company is required to reserve and keep available a sufficient number of shares to satisfy the plan’s requirements. The Company no longer issues equity awards under this plan.
As of September 30, 2026, there was no unrecognized stock-based compensation expense for stock options granted under the STI Plan.
Robotics Plan
On September 17, 2026, the board of directors and stockholders of FF EAI Robotics Inc. ("FF Robotics"), a majority-owned subsidiary of the Company, approved the FF EAI Robotics Inc. 2026 Equity Incentive Plan (the "Robotics Plan"). Following FF Robotics’ 750-for-1 forward stock split in September 2026, the Robotics Plan reserved 25,000,000 shares of FF Robotics common stock for awards to employees, directors and other service providers of FF Robotics and its affiliates.
During three months ended September 30, 2026, FF Robotics granted options to purchase 24,993,210 shares of its common stock. As of September 30, 2026, options to purchase 24,993,200 shares remained outstanding, no options had vested, and 6,800 shares remained available for future grant. The options have a weighted-average exercise price of $0.0472 per share and a contractual term of ten years. Twenty-five percent of the options vest on the six-month anniversary of the vesting commencement date, and the remaining 75% vest in 36 substantially equal monthly installments beginning on the first anniversary, with full vesting on the 47th monthly anniversary. Vesting is subject to continued service; the awards have no performance conditions, and the awards are not subject to performance conditions.
The options are equity-classified awards are measured at grant-date fair value. The weighted-average grant-date fair value was $0.0244 per option, determined using the Black-Scholes option pricing model. The valuation used an underlying common-stock value of $0.0472 per share, based on an independent valuation, an expected term of approximately 5.98 years, expected volatility of 70.00%, a risk-free interest rate of 5.06%, and an expected dividend yield of zero. The total grant-date fair value of the outstanding options was $0.6 million.
Compensation cost for the first 25% of the options is recognized on a straight-line basis over the initial six months, while compensation cost for the remaining 75% is recognized on a straight-line basis over the following 41 months. The Company recognized $5.9 thousand of compensation expense related to these awards for both the three and nine months ended September
30, 2026. Unrecognized compensation cost was $0.6 million as of September 30, 2026 and is expected to be recognized over the remaining service period through August 2030.
Stock-Based Compensation Awards
2021 Plan - Option Awards
As of September 30, 2026, there was no unrecognized stock-based compensation expense for stock options granted under the 2021 Plan. Most options granted under the 2021 Plan vest over a four-year period and are contingent upon the grantee’s continued service.
There were no options granted under the 2021 Plan during the three and nine months ended September 30, 2026.
2021 Plan - Restricted Stock Units and Performance Stock Units
As of September 30, 2026, total unrecognized stock-based compensation expense for RSUs granted under the 2021 Plan was less than $0.1 million. Most RSUs granted under the 2021 Plan vest over a four-year period and are contingent upon the grantee’s continued service, except for RSUs granted to members of the Board of Directors, which generally vest over an approximately one-year period.
On August 17, 2026, the Company granted 330,152 RSUs under the 2021 Plan pursuant to an equity award arrangement approved separately from the temporary salary reductions. The number of RSUs awarded was determined by reference to the applicable reductions in cash compensation. The awards had a grant-date fair value of $3.72 per share and vested in full on August 24, 2026. The Company recognized $1.2 million of stock-based compensation expense for these awards during each of the three and nine months ended September 30, 2026. No compensation cost for these awards remained unrecognized as of September 30, 2026.
Executive Equity Awards
On May 5, 2026, the Board approved compensation arrangements with Yueting Jia, the Company’s Global Chief Executive Officer, and Jiawei (Jerry) Wang, the Company’s Global Executive Chairman, providing for time-based restricted stock unit (“RSU”) awards with stated values of $5.9 million and $1.5 million, respectively, and performance stock unit (“PSU”) awards with target values of $5.9 million and $1.5 million, respectively. The RSUs vest in four equal annual installments, subject to continued employment through each applicable vesting date. Although the Board approved the compensation arrangements on May 5, 2026, the RSU grants remained subject to subsequent approval by the Board or a committee thereof, including confirmation that sufficient shares were available under the 2021 Plan. As of September 30, 2026, such approval had not occurred and, accordingly, a grant date had not been established for the RSU.
The PSUs are subject to the achievement of performance criteria to be established by the Board or a committee thereof. As of September 30, 2026, the applicable performance criteria had not been approved and the parties had not reached a mutual understanding of the key terms and conditions of the awards. In addition, the PSU grants remained subject to subsequent approval by the Board or a committee thereof, including confirmation that sufficient shares were available under the 2021 Plan. Accordingly, a grant date had not been established for the PSUs as of September 30, 2026.
Equity Awards Outside of Company’s Equity Incentive Plans (Market-Based Awards)
Effective April 23, 2025, the Company entered into an offer letter with Mr. Yueting Jia, under which he was appointed to serve as Global Co-CEO. (Currently, Mr. Jia serves as the Company’s Global Chief Executive Officer.) In connection with his service, Mr. Jia is eligible to receive contingent equity awards if the Company achieves certain stock price or market capitalization milestones. These awards are made outside of the Company’s existing equity incentive plans.
The equity award structure consists of two phases:
•Phase 1: For every $750.00 increase, as retrospectively adjusted for the Reverse Stock Split, in the Company's daily closing stock price or $700.0 million increase in market capitalization, measured from April 23, 2025, Mr. Jia is eligible to receive restricted stock units (RSUs) equal to 1% of the Company's outstanding shares at the time the milestone is achieved. Awards under this phase are capped at 5% of the Company’s outstanding shares.
•Phase 2: After reaching the 5% cap under Phase 1, Mr. Jia is eligible to receive additional RSUs for each $3000.00 increase, as retrospectively adjusted for the Reverse Stock Split, in stock price or $3000.0 million
increase in market capitalization, again equal to 1% of outstanding shares per milestone, up to a cumulative total of 9% of outstanding shares.
To qualify for any award, the applicable stock price or market capitalization level must be sustained for at least 15 consecutive trading days. The effects of stock splits, dividends, mergers, or acquisitions are excluded from milestone calculations. There is no expiration date associated with achievement of the award. The award qualifies for equity accounting pursuant to the provisions of ASC 718, however, since the Company previously had insufficient authorized but unissued shares the award was presented as a liability within Accrued Expenses and Other Current Liabilities in the Unaudited Condensed Consolidated Balance Sheet. Following the Reverse Stock Split on July 24, 2026, the Company had sufficient authorized but unissued shares to settle the award and reclassified the award to equity. Immediately before reclassification, the award was remeasured at fair value and the resulting $1.6 million liability was transferred to additional paid-in capital. No liability for this award remained as of September 30, 2026.
The fair value of Mr. Jia’s award at grant date was $10.3 million with an estimated total derived service period of 7.61 years, with expected milestone achievement dates between 2029 and 2032. The fair value of Mr. Jia’s award at July 24, 2026 reclassification date is $7.1 million. As of September 30, 2026, remaining derived service period was 6.18 years. The Company recognizes expense for Mr. Jia’s award using the accelerated attribution method over the derived service period for each tranche. While the award was liability-classified, the award was remeasured at fair value at each reporting date and immediately before reclassification, with changes in fair value recognized as compensation cost based on the portion of the requisite service period rendered. Following equity classification, compensation cost was based on the July 24, 2026 fair value, with no subsequent recurring fair value remeasurement. Unrecognized compensation cost was $5.3 million as of September 30, 2026. Details on key assumptions and inputs used in valuing Mr. Jia’s award can be found at Note 15, Fair Value of Financial Instruments. The derived service period is not subsequently revised unless the related market condition is achieved before the end of the initially derived service period.
The Company began recognizing expense for Mr. Jia’s market-based awards, which are in addition to his annual equity plan, at the inception of the arrangement. The compensation expense recognized in the three and nine months ended September 30, 2026, was a reversal of previously recognized compensation expense of $0.2 million and $0.6 million, respectively, reflecting the decline in the fair value of the award liability before reclassification, partially offset by service cost recognized from reclassification date to September 30, 2026. The compensation expense recognized in the three and nine months ended September 30, 2025 was $1.2 million and $1.9 million.
Stock-based compensation expense
The following table presents stock-based compensation expense related to awards under the Company’s 2021 Plan, EI Plan, STI Plan, FF Robotics’ 2026 Equity Incentive Plan (the “Robotics Plan”), and awards granted outside these plans, by expense category, as recognized in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss :
Three Months Ended September 30,Nine Months Ended September 30,
 (in thousands)2026202520262025
Research and development$390 $22 $406 $357 
Sales and marketing291 4 303 45 
General and administrative338 1,272 (19)(a)2,090 
$1,019 $1,298 $690 $2,492 
(a) Negative stock-based compensation expense in general and administrative due to adjusting down the liability balance of Mr. Jia’s market-based awards and remeasurement of other liability-classified awards.